A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
Public ClinicalTrials.gov record NCT06127043. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ROSETTA STUDY: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe ulcerative colitis (UC)
Study identification
- NCT ID
- NCT06127043
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 132 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2023
- Primary completion
- Dec 31, 2025
- Completion
- Apr 30, 2026
- Last update posted
- Oct 2, 2025
2023 – 2026
United States locations
- U.S. sites
- 25
- U.S. states
- 12
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AnaptysBio Investigational Site 10-115 | Phoenix | Arizona | 85018 | — |
| AnaptysBio Investigational Site 10-117 | Garden Grove | California | 92845 | — |
| AnaptysBio Investigational Site 10-112 | Lancaster | California | 93534 | — |
| AnaptysBio Investigational Site 10-129 | Lancaster | California | 93534 | — |
| AnaptysBio Investigational Site 10-108 | San Jose | California | 95124 | — |
| AnaptysBio Investigational Site 10-127 | Brooksville | Florida | 34601 | — |
| AnaptysBio Investigational Site 10-106 | Miami | Florida | 33165 | — |
| AnaptysBio Investigational Site 10-109 | Miami Gardens | Florida | 33014 | — |
| AnaptysBio Investigational Site 10-131 | Orlando | Florida | 32789 | — |
| AnaptysBio Investigational Site 10-123 | Orlando | Florida | 32822 | — |
| AnaptysBio Investigational Site 10-125 | Tampa | Florida | 33607 | — |
| AnaptysBio Investigational Site 10-122 | Atlanta | Georgia | 30328 | — |
| AnaptysBio Investigational Site 10-124 | Oak Lawn | Illinois | 60453 | — |
| AnaptysBio Investigational Site 10-118 | Las Vegas | Nevada | 89128 | — |
| AnaptysBio Investigational Site 10-133 | Utica | New York | 13501 | — |
| AnaptysBio Investigational Site 10-136 | Cincinnati | Ohio | 45201 | — |
| AnaptysBio Investigational Site 10-120 | Norman | Oklahoma | 73017 | — |
| AnaptysBio Investigational Site 10-103 | Kingsport | Tennessee | 37663 | — |
| AnaptysBio Investigational Site 10-104 | Dallas | Texas | 75246 | — |
| AnaptysBio Investigational Site 10-113 | Garland | Texas | 75044 | — |
| AnaptysBio Investigational Site 10-135 | Georgetown | Texas | 78626 | — |
| AnaptysBio Investigational Site 10-134 | Lubbock | Texas | 79382 | — |
| AnaptysBio Investigational Site 10-130 | Southlake | Texas | 76092 | — |
| AnaptysBio Investigational Site 10-132 | Tyler | Texas | 75701 | — |
| AnaptysBio Investigational Site 10-107 | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06127043, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06127043 live on ClinicalTrials.gov.